Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Form 8.3 - Empresaria Group plc

21 Aug 2025 12:02

RNS Number : 2988W
TrinityBridge Limited
21 August 2025
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TrinityBridge Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Empresaria Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20/08/2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ORDINARY

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,584,973

7.19

 

 

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

3,584,973

7.19

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GB00B0358N07

Purchase

969

£ 0.41

GB00B0358N07

Sale

969

£ 0.41

GB00B0358N07

Sale

9,344

£ 0.4015

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

 

N/A

N/A

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

21/08/2025

Contact name:

Laura Whittam

Telephone number:

+44 (0) 20 8036 8612

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUPURUPAGGG
Date   Source Headline
6th Sep 20127:00 amRNSHalf Yearly Report
15th Aug 20127:00 amRNSAcquisition of additional shares in MediradiX
13th Jul 201212:14 pmRNSAcquisition of further stake in subsidiary
31st May 201211:20 amRNSDirector Dealing
29th May 20121:00 pmRNSResult of AGM
29th May 20127:00 amRNSAGM Statement
22nd May 201210:19 amRNSDirector Dealing
21st May 20122:49 pmRNSDirctor Dealing
25th Apr 20121:55 pmRNSDirector Dealing
20th Apr 201210:08 amRNSNotice of AGM
21st Mar 20127:00 amRNSFinal Results
13th Mar 20127:00 amRNSSubsidiary mgmt change and option amendments
27th Jan 20127:00 amRNSAcquisition of further stake in subsidiary
24th Jan 201211:02 amRNSHolding(s) in Company
19th Jan 20127:00 amRNSTrading Update
22nd Dec 20117:00 amRNSAppointment of Broker
15th Dec 20114:27 pmRNSDirectorate Changes
8th Dec 20114:52 pmRNSHolding(s) in Company
6th Dec 20117:00 amRNSAcquisition of further stake in subsidiary
28th Oct 201111:05 amRNSHolding(s) in Company (replacement)
27th Oct 20115:39 pmRNSHolding(s) in Company
4th Oct 20114:04 pmRNSAwards pursuant to the Company's LTIP
8th Sep 20117:00 amRNSHalf Yearly Report
7th Jun 201112:55 pmRNSResult of AGM
7th Jun 201112:30 pmRNSAGM Statement
3rd May 201111:36 amRNSAnnual Report & Accounts and Notice of AGM
31st Mar 20117:00 amRNSFinal Results
31st Jan 20117:00 amRNSTrading Update
16th Dec 20107:00 amRNSChange of Adviser
8th Nov 20109:51 amRNSDirector/PDMR Shareholding
8th Oct 201010:00 amRNSAcquisition of minority stake
9th Sep 20107:00 amRNSHalf Yearly Report
26th Jul 20107:00 amRNSChange of Registered Office
23rd Jun 20102:35 pmRNSHolding(s) in Company
10th Jun 20104:13 pmRNSHolding(s) in Company
3rd Jun 20103:07 pmRNSCorrection - Directors Dealings
3rd Jun 20102:27 pmRNSDirector/PDMR Shareholding
3rd Jun 20101:04 pmRNSResult of AGM
3rd Jun 20107:00 amRNSAGM Statement
5th May 20107:00 amRNSNotice of AGM
27th Apr 20107:00 amRNSDirectorate Change
14th Apr 20107:00 amRNSDisposal
25th Mar 20104:49 pmRNSDirector/PDMR Shareholding
25th Mar 20107:00 amRNSFinal Results
21st Jan 20107:00 amRNSTrading Update
9th Dec 20098:05 amRNSDirector/PDMR Shareholding
3rd Dec 20095:19 pmRNSDirector/PDMR Shareholding
10th Sep 20097:00 amRNSInterim Results
6th Jul 20092:00 pmRNSIssue of Equity
25th Jun 20093:20 pmRNSAcquisition of minority stake and issue of equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.